Stock

Indivior Pharmaceuticals, Inc. INDV

$40.49-0.01%

All stocks Create account to unlock

Overview

INDV market data

Price History

INDV price chart

Valuation & Profitability

no valuation data

No Valuation Data Yet

Alpha Vantage and Twelve Data both returned no valuation metrics for INDV. Check back after the next daily valuation refresh — this symbol may be new, delisted, or temporarily unavailable from both providers.

Company news

5 captured

Indivior to Report Second Quarter 2026 Financial Results and Host Webcast · Jul 23, 2026, 2:15 PM

Barclays Initiates Coverage On Indivior Pharmaceuticals with Overweight Rating, Announces Price Target of $46 · Jun 18, 2026, 12:55 PM

Herantis reports positive FDA feedback and finalizes Phase 2a study design for HER-096 · Jun 2, 2026, 11:15 AM

Indivior Pharma Announces Findings From Two New Real-World Evidence Studies Show Adherence To Extended-Release Buprenorphine Is Associated With Lower Relapse Risk And Reduced Healthcare Utilization · May 20, 2026, 1:10 PM

8-K filing — Indivior Pharmaceuticals, Inc. (INDV) · May 4, 2026, 11:00 AM

Decision & Score

Members

Our Tradable / Watch / Avoid decision and 0–100 conviction score for this symbol are members-only.

Create account to unlock

Trend & Pattern Evidence

Members

Trend alignment and backtested chart-pattern probabilities are members-only.

Create account to unlock

Sector Peer Ranking

Members

Ranked sector peers with scores and decisions are members-only.

Create account to unlock